Morning vs evening inhalation of dornase alfaMeasures of QoL and symptom scores · adults and children with cystic fibrosis1 finding from 1 reviewTiming of dornase alfa inhalation for cystic fibrosis 2021 · Cochrane Headline outcomes onlyno estimate extracted25 participantsLow
HC (13.5 mg/m²/day to 15.5 mg/m²/day): high morning dose vs high evening doseQoL · people with CAHThe review found no eligible studies for this question.1 finding from 1 reviewGlucocorticoid replacement regimens for treating congenital adrenal hyperplasia 2020 · Cochrane Headline outcomes onlyno estimate extractedStudies not reportedNo studies found